-
Famous GLP-1RA Outside of the Circle, and Rapid Development of Peptide CDMO
Xiaobin/PharmaSources
August 07, 2023
With the famous weight-loss drugs are famous outside of the circle, such as GLP-1RA, it has also stimulated the market's demand and concern for peptide CDMO.
-
Latest Trends in Pharmaceutical Industry
Muhammad Asim Niazi
June 14, 2023
Recent years have seen innovation in many fields, such as software and computing.For the pharmaceutical industry, these latest trends have changed the paradigm of every field.
-
How to Select a CDMO for your company?
Muhammad Asim Niazi
May 08, 2023
Under their guidelines and quality checks, CDMO use these resources to produce or manufacture for other pharma organizations.
-
The Increasing ADC+CDMO Industry Collaboration
Yefenghong/PharmaSources
April 19, 2023
Recently, the heat on ADC pipeline deals is around, and the deal sizes are kept refreshing.
-
With First Chinese Small-molecule Oral Drug for COVID-19 Coming, What New Opportunities are Ushered in by the Relevant Industry Chain?
PharmaSources.com/Yefenghong
May 23, 2022
News about the progress of Chinese small-molecule oral antiviral drug for COVID-19 has been disclosed in recent days and the related R&D ushers in a critical point.
-
Vetter Looks Ahead to Further Expansions to Meet Supply Chain Demand
B3C newswire
November 06, 2023
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announces additional investments as part of its long-term dedication to customer partnerships.
-
Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time
PharmaSources
August 30, 2023
On August 29, 2023,Vetter has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers.
-
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic
PharmaSources
August 03, 2023
On August 03, 2023,Celonic Group has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER & Söhne Company (JRS Group).
-
Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives
PharmaSources
June 15, 2023
On June 14, 2023,Vetter, one of the world's leading Contract Development and Manufacturing Organizations, is consistently pursuing improvements to its sustainability strategy.
-
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site
PharmaSources
May 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.